[过敏性支气管肺阿斯伯吉洛症 (ABPA) - 一个更新]
Pneumologie (Stuttgart, Germany)
|February 28, 2024
概括
过敏性支气管肺性阿斯伯吉洛症 (ABPA) 是一种肺部疾病,常见于严重喘,囊性纤维化和菌过敏患者. 早期诊断和使用类固醇,抗真菌药物或生物药物的治疗可以预防严重的肺损伤.
科学领域:
- 肺部病理学 肺部病理学
- 过敏学 过敏学
- 传染性疾病 传染性疾病
背景情况:
- 过敏性支气管肺性阿斯伯吉洛症 (ABPA) 是一种常见的肺部并发症.
- 它经常发生在患有严重喘,囊性纤维化和菌过敏的患者中.
- 延迟诊断可能导致不可逆转的肺损伤,如支气管切除和纤维化.
研究的目的:
- 强调早期ABPA诊断的重要性.
- 概述诊断标准和治疗策略.
- 强调生物制剂在ABPA管理中的不断变化的作用.
主要方法:
- 对ABPA的临床表现和诊断标准的审查.
- 分析当前的治疗方法,包括全身类固醇,抗真菌药物和生物药物.
- 讨论患有ABPA风险较高的患者群体.
主要成果:
- 在有风险的患者中,尽管有非特异性症状,但ABPA诊断需要考虑.
- 确定的诊断标准有助于早期识别.
- 系统性类固醇和醇抗真菌药物是主要的治疗方法,而生物药物提供了新的选择.
结论:
- 早期诊断ABPA对于预防严重的肺部并发症至关重要.
- 敏感患者的高怀疑指数是必不可少的.
- 治疗策略正在发展,生物药物对耐火病例显示出前景.
更多相关视频
08:01Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
28.0K
15:01Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
Published on: September 18, 2021
3.4K
相关概念视频
Asthma: Pathogenesis and Management
396
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
246
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
246
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
